We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Here are relevant reports on : urea-cycle-disorder-ucd-drugs-market

  • Amino resins are thermosetting resins formed by copolymerization of amino compounds with an aldehyde. Amino resins are used in wood panels, coatings, laminates, molding compounds, adhesives, and other industry.Amino resins are majorly used as adhesives in wood panels such as particleboards, MDF, plywood, etc. The high performance of amino resins in terms of strength and resistance they provide to wood panels are major driver of amino resin market.

    • Published: April 2013
    • Price: $ 4950
    • TOC Available:
  • The Insights-as-a-Service market size is expected to grow from USD 1.16 Billion in 2016 to USD 3.33 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.5% during the forecast period. The major drivers of this market include the need for improved customer satisfaction and operational performance.

    • Published: December 2016
    • Price: $ 4950
    • TOC Available:
  • The global therapeutic drug monitoring market growth is primed to transition from USD 2.30 billion in 2024 to USD 3.44 billion by 2029, showcasing a strong CAGR of 8.4%. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.In addition, the development of advanced and highly sensitive immunoassay methods including fluorescence, chemiluminescence, and ELISA is also contributing considerably to the expansion of the TDM industry.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • The Organic Rankine Cycle (ORC) market is expected to experience significant growth and positive outlook in the coming years. ORC is a thermodynamic cycle that uses organic fluids to convert heat energy into useful mechanical or electrical power.

    • Published: February 2025
    • Price: $ 4950
    • TOC Available:
  • Thrombosis drugs refer to medications that are used to prevent or treat blood clots that form inside blood vessels, which can lead to serious medical conditions such as heart attack, stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). These drugs work by either preventing the formation of clots (anticoagulants) or dissolving existing clots (thrombolytics). The market for thrombosis drugs includes both prescription and over-the-counter medications.

    • Published: February 2025
    • Price: $ 4950
    • TOC Available:
  • The COVID-19 vaccines & drugs market is expected to grow from USD 2,273 million in 2022 to USD 1,401 million by 2025 at a compound annual growth rate (CAGR) of 14.9% during the forecast period.Key players in the COVID-19 vaccines market include Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium) among others.

    • Published: May 2020
    • Price: $ 4950
    • TOC Available:
  • Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share

    • Published: February 2025
    • Price: $ 4950
    • TOC Available:
  • The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.

    • Published: April 2010
    • Price: $ 4950
    • TOC Available:
  • There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.

    • Published: February 2025
    • Price: $ 4950
    • TOC Available:
  • Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.

    • Published: May 2010
    • Price: $ 4950
    • TOC Available:

Records 1 to 10 of 50

DMCA.com Protection Status